Status:
COMPLETED
Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection
Lead Sponsor:
University Hospital, Essen
Conditions:
Cardiovascular Diseases
Cardiovascular Risk Factor
Eligibility:
All Genders
18+ years
Brief Summary
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) a...
Eligibility Criteria
Inclusion
- Patients with suspected SARS-CoV2/Covid-19 infection
Exclusion
- Unwillingness to participate
Key Trial Info
Start Date :
March 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 25 2022
Estimated Enrollment :
728 Patients enrolled
Trial Details
Trial ID
NCT04327479
Start Date
March 26 2020
End Date
July 25 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Essen
Essen, North Rhine-Westphalia, Germany, 45147